Literature DB >> 17376946

In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus?

David Herd1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376946      PMCID: PMC2083685          DOI: 10.1136/adc.2006.112441

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  12 in total

1.  The future diagnostic role of procalcitonin levels: the need for improved sensitivity.

Authors:  Eric Nylen; Beat Muller; Kenneth L Becker; Richard Snider
Journal:  Clin Infect Dis       Date:  2003-03-15       Impact factor: 9.079

2.  Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs.

Authors:  A G Lacour; A Gervaix; S A Zamora; L Vadas; P R Lombard; J M Dayer; S Suter
Journal:  Eur J Pediatr       Date:  2001-02       Impact factor: 3.183

3.  Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher).

Authors:  Barbara W Trautner; A Chantal Caviness; Gary R Gerlacher; Gail Demmler; Charles G Macias
Journal:  Pediatrics       Date:  2006-07       Impact factor: 7.124

Review 4.  Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children.

Authors:  Allen L Hsiao; M Douglas Baker
Journal:  Curr Opin Pediatr       Date:  2005-02       Impact factor: 2.856

5.  Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

Authors:  D Gendrel; J Raymond; J Coste; F Moulin; M Lorrot; S Guérin; S Ravilly; H Lefèvre; C Royer; C Lacombe; P Palmer; C Bohuon
Journal:  Pediatr Infect Dis J       Date:  1999-10       Impact factor: 2.129

6.  Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome.

Authors:  E R Alpern; E A Alessandrini; L M Bell; K N Shaw; K L McGowan
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

7.  Is procalcitonin useful in early diagnosis of serious bacterial infections in children?

Authors:  Sudhin Thayyil; Mohan Shenoy; Mainga Hamaluba; Anil Gupta; John Frater; Ian G Verber
Journal:  Acta Paediatr       Date:  2005-02       Impact factor: 2.299

8.  Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center.

Authors:  Annick Galetto-Lacour; Samuel A Zamora; Alain Gervaix
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

9.  Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.

Authors:  Anna Fernández Lopez; C Luaces Cubells; J J García García; J Fernández Pou
Journal:  Pediatr Infect Dis J       Date:  2003-10       Impact factor: 2.129

Review 10.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Authors:  Liliana Simon; France Gauvin; Devendra K Amre; Patrick Saint-Louis; Jacques Lacroix
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

View more
  2 in total

1.  Lack of value of midregional pro-adrenomedullin and C-terminal pro-endothelin-1 for prediction of severe bacterial infections in infants with fever without a source.

Authors:  Javier Benito; Carlos Luaces-Cubells; Santiago Mintegi; Eider Astobiza; Lorea Martinez-Indart; Ana Valls-Lafont; Juan-José García-García
Journal:  Eur J Pediatr       Date:  2013-06-22       Impact factor: 3.183

Review 2.  Host biomarkers and paediatric infectious diseases: from molecular profiles to clinical application.

Authors:  H K Brand; P W M Hermans; R de Groot
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.